Comparing the current results to its competitors, Singular Genomics Systems Inc reported Revenue decrease in the 3 quarter 2024 year on year by -12.12 %, despite the revenue increase by the most of its competitors of 1.84 %, recorded in the same quarter.
Singular Genomics Systems Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 91.25 %
Singular Genomics Systems Inc 's Comment on Competition and Industry Peers
The company faces competition from Pacific Biosciences Inc., Element Biosciences, Inc., Ultima Genomics, Inc., and Thermo Fisher Scientific Inc., each offering products or developing technologies that compete to varying degrees with some of the company's product solutions. These competitors may possess greater financial resources, larger research and development teams, or more established marketing and sales operations. Additionally, other competitors are developing novel technologies for the life sciences market that could result in rival or replacement products. The company identifies its proprietary Sequencing Engine as a key differentiator from its competitors.
Publicly Traded Peers of Singular Genomics Systems Inc
Agilent Technologies inc Share Performance
+5.55%
This Year
Agilent Technologies inc
Profile
Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.
Mettler toledo International Inc Share Performance
+11.55%
This Quarter
Mettler toledo International Inc
Profile
Mettler Toledo International Inc. operates on a business model that focuses on providing high-quality precision instruments and solutions tailored for various industries, including pharmaceuticals, food production, and laboratory research. The company emphasizes innovation and customer-centric service, delivering advanced technology and software alongside its instruments to enhance operational efficiency and accuracy. Additionally, Mettler Toledo generates recurring revenue through maintenance services, calibration, and consumables associated with its products, fostering long-term relationships with its clients.
Nautilus Biotechnology Inc's business model focuses on using advanced genomics and proteomics technologies to analyze and understand the human proteome.
Pacific Biosciences Of California Inc Share Performance
-1.53%
Over The Past 5 Days
Pacific Biosciences Of California Inc
Profile
Pacific Biosciences of California Inc's business model revolves around the development and commercialization of innovative sequencing systems that enable scientists and researchers to study the complexity of biology. They provide high-resolution genetic analysis solutions, offering a comprehensive platform that includes consumables, systems, and data analysis software to support genomic analysis.
Sources:
Singular Genomics Systems Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Singular Genomics Systems Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
